Cargando…
Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy
OBJECTIVE: To develop a novel prenatal assay based on selective analysis of cell-free DNA in maternal blood for evaluation of fetal Trisomy 21 (T21) and Trisomy 18 (T18). METHODS: Two hundred ninety-eight pregnancies, including 39 T21 and seven T18 confirmed fetal aneuploidies, were analyzed using a...
Autores principales: | Sparks, Andrew B, Wang, Eric T, Struble, Craig A, Barrett, Wade, Stokowski, Renee, McBride, Celeste, Zahn, Jacob, Lee, Kevin, Shen, Naiping, Doshi, Jigna, Sun, Michel, Garrison, Jill, Sandler, Jay, Hollemon, Desiree, Pattee, Patrick, Tomita-Mitchell, Aoy, Mitchell, Michael, Stuelpnagel, John, Song, Ken, Oliphant, Arnold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500507/ https://www.ncbi.nlm.nih.gov/pubmed/22223233 http://dx.doi.org/10.1002/pd.2922 |
Ejemplares similares
-
Non-Invasive Prenatal Detection of Trisomy 21 Using Tandem Single Nucleotide Polymorphisms
por: Ghanta, Sujana, et al.
Publicado: (2010) -
Hemolysis and Fetal Fraction in Cell-Free DNA Blood Collection Tubes for Noninvasive Prenatal Testing
por: Stokowski, Renee, et al.
Publicado: (2020) -
Clinical performance of non‐invasive prenatal testing (NIPT) using targeted cell‐free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studies
por: Stokowski, Renee, et al.
Publicado: (2015) -
GSEPD: a Bioconductor package for RNA-seq gene set enrichment and projection display
por: Stamm, Karl, et al.
Publicado: (2019) -
The fetal fraction of cell-free DNA in maternal plasma is not affected by a priori risk of fetal trisomy
por: Brar, Herb, et al.
Publicado: (2013)